Core Scientific, Inc./tx
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.16B | $-347.2M | $-144.0M | $-936.8M | $576.3M | $-291.1M | $-455.3M | $-902.2M |
| Depreciation & Amortization | — | $16.6M | — | — | $19.7M | — | — | — |
| Depreciation | $15.3M | $16.4M | — | $18.6M | $19.5M | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $17.8M | — | — | $16.2M | — | — | — |
| Net Cash from Operating Activities | $-18.9M | $249.9M | $131.8M | $34.0M | $-45.0M | — | $5.7M | $1.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $565.0M | $389.2M | $244.5M | $121.3M | $84.0M | — | $31.2M | $3.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-386.7M | — | — | $-89.0M | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $971.4M | — | — | $-4.2M | — | — | — |
| Net Change in Cash | — | $834.6M | — | — | $-138.3M | — | — | — |
| Free Cash Flow | $-583.9M | $-139.3M | $-112.7M | $-87.3M | $-129.0M | — | $-25.5M | $-1.9M |